| bibliographicCitation |
Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H, Godefroy O, Deramond H, Etcharry Bouyx F, Pasco Papon A, Dartigues J, Allard M, Rouaud O, Ricolfi F, Moreaud O, Krainik A, Pasquier F, Bomboi S, Delmaire C, Couratier P, Maubon A, Vighetto A, Croisile B, Louis-Tisserand G, Ceccaldi M, Girard N, Michel B, Peretti M, Touchon J, Bonafe A, Benetos A, Barroche G, Bracard S, Vercelletto M, Calvier Auffray E, Robert P, Chanalet S, Dubois B, Hampel H, Dormont D, Lehericy S, Hugon J, Pancrazi MP, Reizine D, Gil R, Vandermarcq P, Novella JL, Pierot L, Belliard S, Carsin M, Martinaud O, Gerardin E, Laurent B, Barral F, Sellal F, Ousset P, Puel M, Ait Ameur A, Dumas H, Mondon K, Cottier J. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease. Neuropharmacology. 2016 Sep;108():128–35. doi: 10.1016/j.neuropharm.2016.02.005. |